Literature DB >> 1311139

Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction.

M Grasso1, E Arbustini, E Silini, M Diegoli, E Percivalle, G Ratti, M Bramerio, A Gavazzi, M Vigano, G Milanesi.   

Abstract

A polymerase chain reaction (PCR) amplification assay was developed to detect Coxsackievirus B3 ribonucleic acid (RNA) in blood and myocardial tissue of explanted hearts from 40 patients who underwent cardiac transplantation and in 1 normal heart. Twenty-one patients were affected by idiopathic dilated cardiomyopathy of different duration and 19 by coronary artery disease. Coxsackievirus B3 in vitro infected Vero cells and cells infected by related human enteroviruses (Coxsackievirus B2, B4, and poliovirus 1) were used as reaction controls. PCR was performed using 4 pairs of primers homologous to Coxsackie-virus B3 sequences. Three sets were located in regions of the genome conserved at nucleotide level between several enterovirus species (replicase gene, 5' noncoding region), while one was located in a Coxsackievirus B3-specific region (VP1 gene). Total RNA was prepared by acid guanidinium isothiocyanate extraction from tissue stored frozen at -80 degrees C. One microgram of total RNA was retrotranscribed with either antisense primer or with random hexanucleotide primers and then subjected to 40 cycles of amplification. PCR products were separated by electrophoresis on a 10% polyacrylamide gel, electrotransferred to a nylon membrane and then hybridized to oligonucleotide probes specific for the coxsackievirus B3 genome radiolabeled with radioactive isotope of phosphorous. All pairs of primers yielded specific amplification products when tested on Coxsackievirus B3-infected Vero cells, with a sensitivity of 1 infected cell out of 10(5) to 10(6) cells starting from 1 microgram total RNA. Primer sets for regions of Coxsackievirus B3 genome highly conserved between related enteroviral species gave positive amplification also when challenged with RNA from cells infected by Coxsackievirus B2, B4 and poliovirus 1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311139     DOI: 10.1016/0002-9149(92)90160-z

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  eHEART: www.heartjnl.com.

Authors: 
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Absence of viral nucleic acids in early and late dilated cardiomyopathy.

Authors:  N G Mahon; B Zal; G Arno; P Risley; J Pinto-Basto; W J McKenna; M J Davies; C Baboonian
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Reverse transcription PCR to detect enteroviruses in surface water.

Authors:  M Gilgen; B Wegmüller; P Burkhalter; H P Bühler; U Müller; J Lüthy; U Candrian
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

Review 4.  Familial dilated cardiomyopathy.

Authors:  L Mestroni; M Krajinovic; G M Severini; B Pinamonti; A Di Lenarda; M Giacca; A Falaschi; F Camerini
Journal:  Br Heart J       Date:  1994-12

Review 5.  Link between enteroviruses and dilated cardiomyopathy: serological and molecular data.

Authors:  P J Keeling; S Tracy
Journal:  Br Heart J       Date:  1994-12

Review 6.  Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.

Authors:  Cristina Basso; Fiorella Calabrese; Annalisa Angelini; Elisa Carturan; Gaetano Thiene
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 7.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction.

Authors:  P J Keeling; S Jeffery; A L Caforio; R Taylor; G F Bottazzo; M J Davies; W J McKenna
Journal:  Br Heart J       Date:  1992-12

Review 9.  Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies.

Authors:  Matthias Pauschinger; Kumaran Chandrasekharan; Michel Noutsias; Uwe Kühl; Lothar Peter Schwimmbeck; Heinz-Peter Schultheiss
Journal:  Med Microbiol Immunol       Date:  2004-01-14       Impact factor: 3.402

10.  Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection.

Authors:  G N Dalekos; K Achenbach; D Christodoulou; G K Liapi; E K Zervou; D A Sideris; E V Tsianos
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.